• Tue news: Where do Harris and Trump stand on health policy? Medtronic renal denervation coverage. Canada less likely to have drug shortages? Wall Street wants CVS execution plan. Nektar manufacturing facility sale. See more on our front page

What have all the good ones left?

Anonymous

Guest
Letting Paul Fonteyne get away to BI was a huge mistake. His record of excellence and achievement at BI speaks quite well for itself. For that matter, we never should have let Marty Carroll get away either.